rxstat › Shortages › Terazosin

Terazosin shortage status

No current shortage

Source: Health Canada shortage reports · Updated Jul 9, 2026

Terazosin has no current shortage reported in Canada. It has been in shortage before; the history is below.
Products affected
0 / 18
Reports on file
47

Reports by product

Resolved
TEVA-TERAZOSIN
2MG · TABLET · TEVA CANADA LIMITED
DIN 02230806 · ended Apr 7, 2025 · Disruption of the manufacture of the drug.
Resolved
TEVA-TERAZOSIN
10MG · TABLET · TEVA CANADA LIMITED
DIN 02230808 · ended Apr 7, 2025 · Disruption of the manufacture of the drug.
Resolved
TEVA-TERAZOSIN
1MG · TABLET · TEVA CANADA LIMITED
DIN 02230805 · ended Apr 7, 2025 · Disruption of the manufacture of the drug.
Discontinued
TEVA-TERAZOSIN
5MG · TABLET · TEVA CANADA LIMITED
DIN 02230807
Resolved
TEVA-TERAZOSIN
5MG · TABLET · TEVA CANADA LIMITED
DIN 02230807 · ended Jun 16, 2025 · Disruption of the manufacture of the drug.
Resolved
PMS-TERAZOSIN
10MG · TABLET · PHARMASCIENCE INC
DIN 02243521 · ended May 22, 2025 · Disruption of the manufacture of the drug.
Resolved
APO-TERAZOSIN
5MG · TABLET · APOTEX INC
DIN 02234504 · ended May 9, 2024 · Disruption of the manufacture of the drug.
Resolved
APO-TERAZOSIN
10MG · TABLET · APOTEX INC
DIN 02234505 · ended May 9, 2024 · Shortage of an active ingredient.
Resolved
APO-TERAZOSIN
2MG · TABLET · APOTEX INC
DIN 02234503 · ended May 9, 2024 · Disruption of the manufacture of the drug.
Resolved
APO-TERAZOSIN
1MG · TABLET · APOTEX INC
DIN 02234502 · ended Apr 1, 2024 · Shortage of an active ingredient.
Resolved
APO-TERAZOSIN
2MG · TABLET · APOTEX INC
DIN 02234503 · ended Apr 1, 2024 · Shortage of an active ingredient.
Resolved
APO-TERAZOSIN
5MG · TABLET · APOTEX INC
DIN 02234504 · ended Apr 1, 2024 · Shortage of an active ingredient.

Showing 12 of 47 reports. All reports are on file with Health Canada.

What's happening

There are no active shortage reports for Terazosin. Health Canada has 47 historical reports on file for this drug, so supply has been disrupted before; the change log below shows the history.

Terazosin is classified under “DRUGS USED IN BENIGN PROSTATIC HYPERTROPHY” (ATC G04CA).

Recent changes

Common questions

When will Terazosin be back in stock in Canada?

Terazosin has no active shortage; supply is normal per Health Canada reports.

Why is Terazosin in shortage?

It isn't currently. Past reports and their reasons are listed above.

What can my pharmacist do about it?

Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.

Related drugs (drugs used in benign prostatic hypertrophy)

Partial shortageAlfuzosin1 of 6 reported products affected · est. return Jun 26, 2026Partial shortageDutasteride1 of 12 reported products affected · est. return Aug 1, 2026Partial shortageFinasteride2 of 18 reported products affected · est. return Dec 31, 2026Partial shortageTamsulosin4 of 10 reported products affected · est. return Nov 13, 2026No current shortageSilodosinNo current shortageTamsulosin Dutasteride

Guides: what to do when your medication is in shortage · how to read shortage reports

Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.